CD44+/CD24- Cells in Basal-like Breast Tumors
Author Information
Author(s): Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt
Primary Institution: Lund University
Hypothesis
The presence of CD44+/CD24- cells within breast tumors has clinical implications and is associated with specific breast cancer subtypes.
Conclusion
The study shows a strong association between the CD44+/CD24- phenotype and basal-like breast tumors, particularly in BRCA1 hereditary cases.
Supporting Evidence
- CD44+/CD24- cells were detected in 31% of the tumors.
- 94% of BRCA1 hereditary tumors contained CD44+/CD24- cells.
- CD44+/CD24- status was significantly correlated with low/negative HER2 expression.
Takeaway
Some breast cancer cells have special markers that might help them grow and spread. This study found that a certain type of these cells is more common in aggressive breast cancers.
Methodology
Double-staining immunohistochemistry was used to analyze CD44 and CD24 expression in 240 human breast tumors.
Potential Biases
Potential bias in tumor selection and the retrospective nature of the study.
Limitations
The study may not fully represent all breast cancer types due to the specific focus on stage II tumors.
Participant Demographics
Patients aged 31 to 81 years, diagnosed with stage II breast cancer.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website